NCT02311556View on ClinicalTrials.gov

Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 7, 2013

Primary Completion Date

July 1, 2016

Study Completion Date

December 16, 2016

Conditions

Brain Metastases

Interventions

DEVICE

dynamic susceptibility-weighted contrast-enhanced perfusion magnetic resonance imaging

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02311556 - Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter